N/A
N=1,747
Interventions to Increase HBV Vaccinations in Sexually Transmitted Disease (STD) Clinics
Hepatitis B Virus
Bottom Line
View on ClinicalTrials.gov: NCT00739752 ↗Enrolled (actual)
1,747
Serious AEs
0.0%
Results posted
Oct 2017
Primary outcome: Primary: Mean Number of Doses of HBV Vaccine Received — .78; .85; .94; .98 Doses of HBV Vaccine — p==.885
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Non-Framed-Offered (Behavioral); Non-Framed-Recommended (Behavioral); Gain-Framed-Offered (Behavioral); Gain-Framed-Recommended (Behavioral); Loss-Framed-Offered (Behavioral); Loss-Framed-Recommended (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Indiana University
- Primary completion
- Jun 2007
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Mean Number of Doses of HBV Vaccine Received |
.78; .85; .94; .98; .81; 1.10 | =.885 |
Summary
The goal of this study is to evaluate two sets of interventions to increase acceptance of hepatitis B virus (HBV) vaccination in patients attending sexually transmitted disease (STD) clinics. The 1st set of interventions, with 3 levels, is based on message framing. The 3 levels are: 1. information only; 2. gain-framed message; and 3. loss-framed message. The 2nd set of interventions, with 2 levels, involves how the vaccine is recommended by the health care provider. The 2 levels are: 1. HBV vaccine offered; and 2. HBV vaccine recommended. The outcome of interest is1st dose acceptance.
Eligibility Criteria
Inclusion Criteria
- Age 18 and older males and females
- No prior self-reported history of HBV immunization or infection
- Fluent in English
- Not known to be HIV positive.
Exclusion Criteria
- Under age 18
- Received any prior HBV vaccination
- Prior infection of Hepatitis B
- Unable to read or comprehend the English language
- HIV positive
Data sourced from ClinicalTrials.gov (NCT00739752). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.